BUSINESS NEWS
Find articles by title or summary.
The Coast Guard will enforce a security zone along the Potomac and Anacostia Rivers and adjacent waters at Washington, DC to protect government officials and enhance public and maritime safety and security ahead of the 60th Presidential Inauguration.
The Federal Aviation Administration (FAA) amends the Class E airspace at Gaylord, MI, to comply with FAA orders and support instrument flight rule procedures and operations, following the decommissioning of the Gaylord VOR as part of the VOR Minimum Operational Network Program.
The Federal Aviation Administration (FAA) amends the Class E airspace at Pontiac, IL, due to the decommissioning of the Pontiac VOR as part of the VOR Minimum Operational Network (MON) Program.
The Federal Aviation Administration (FAA) amends the Class E airspace at Smith Center, Kansas, due to the decommissioning of the Mankato VOR as part of the VOR Minimum Operational Network Program.
The Federal Aviation Administration (FAA) amends the Class E airspace at El Dorado, AR, to coincide with the FAA's aeronautical database and support instrument flight rule (IFR) procedures and operations.
The Federal Aviation Administration (FAA) has revoked the Class E airspace at Follett, TX, due to the cancellation of instrument procedures at the airport.
The Federal Aviation Administration (FAA) amends the Class E airspace at Giddings, TX, to coincide with the FAA's aeronautical database and support instrument flight rule (IFR) operations, following the decommissioning of the Industry VOR as part of the VOR Minimum Operational Network (MON) Program.
The Federal Aviation Administration proposes establishing Class E airspace at Blanding Municipal Airport in Utah, revoking existing airspace, and updating the airport's legal description to support instrument flight rules operations.
The Federal Aviation Administration proposes modifying Class E airspace at Battle Mountain Airport in Nevada to support instrument flight rules operations and update legal descriptions.
The US Environmental Protection Agency has finalized the technology review for commercial and industrial dry cleaning facilities using perchloroethylene, but will not implement changes due to a 10-year phaseout of PCE under the Toxic Substance Control Act.
The Environmental Protection Agency (EPA) is correcting a typographical error in the Review of Final Rule Reclassification of Major Sources as Area Sources Under Section 112 of the Clean Air Act final rule published on September 10, 2024.
The United States Environmental Protection Agency (EPA) has received applications to register new uses for pesticide products containing currently registered active ingredients, with the public invited to comment on these applications.
The Environmental Protection Agency (EPA) is announcing the availability of a draft risk evaluation for Dicyclohexyl phthalate (DCHP) and seeking public comment, citing unreasonable risk to human health.
The U.S. Nuclear Regulatory Commission will prepare a supplement to its 2020 environmental impact statement for the license renewal of Peach Bottom Atomic Power Station Units 2 and 3, addressing new information since the final statement was issued.
The US Nuclear Regulatory Commission has granted an exemption to Constellation Energy Generation, LLC, allowing the LaSalle County Station to store spent fuel in a non-compliant condition, pending compliance with specific terms and conditions.
The National Highway Traffic Safety Administration (NHTSA) has finalized a rule to improve the ease-of-use of child restraint systems in vehicles, including lower and tether anchorages, and to maintain their effectiveness. This rule fulfills a mandate from the Moving Ahead for Progress in the 21st Century Act (MAP-21) to enhance child restraint systems in all rear seat positions.
The U.S. International Trade Commission has received a complaint about Certain Shapewear Garments and Components Thereof and is now soliciting public comments on any public interest issues related to the complaint or the filing.
The US Commission has scheduled the final phase of an investigation into whether imports of solar panels from Cambodia, Malaysia, Thailand, and Vietnam are harming the US solar panel industry, following preliminary findings that the products are subsidized and sold at less-than-fair-value.
The US International Trade Commission has launched investigations into Chinese slag pots imported into the US, alleging they are sold at below fair value and subsidized by the Chinese government, with a preliminary decision due by February 14, 2025.
The FDA has released a draft guidance for industry and FDA staff on validating in vitro diagnostic devices for emerging pathogens during a public health emergency, including a Section 564 declared emergency.
The FDA has announced the availability of draft guidances to update guidelines for reducing the risk of transmission of hepatitis B, C, and HIV through human cells, tissues, and cellular and tissue-based products.
The FDA has released a draft guidance document outlining recommendations for determining the eligibility of donors of human cells, tissues, and cellular and tissue-based products, with plans to issue additional guidance on reducing the risk of communicable disease transmission.
The Food and Drug Administration (FDA) has released a final guidance for industry on Animal Food Ingredient Consultation (AFIC), outlining a process for engagement with FDA regarding animal food ingredients, and explaining how the agency will work with firms developing these ingredients following the expiration of its Memorandum of Understanding with AAFCO on October 1, 2024.
The FDA has released a draft guidance document to encourage the consideration of sex and/or gender in medical device clinical studies, aiming to improve the safety and effectiveness of devices.
The FDA has released a draft guidance outlining its interpretation of 'underway' for confirmatory trials of drugs granted accelerated approval, aiming to clarify policies for implementing this requirement.
The US Food and Drug Administration (FDA) has published a draft guidance on establishing sanitation programs for low-moisture ready-to-eat human foods to prevent pathogen contamination, with the aim of taking corrective actions following a contamination event.
The FDA is releasing a final guidance document to help staff and interested parties evaluate the public health importance of food allergens beyond the major allergens listed in the FD&C Act. This guidance outlines the FDA's approach to assessing the risks associated with these lesser-known allergens.
The FDA has released a draft guidance outlining its policy on heritable intentional genomic alterations in animals used for biomedical research, specifically those intended for use as models of human or animal disease in controlled conditions.
The FDA is announcing the availability of a draft guidance for industry #260 on Type VII Veterinary Master Files for research and development and risk reviews, which will outline the agency's current thinking on the use of these files for various animal-related products.
The US Food and Drug Administration (FDA) has issued a final guidance document outlining its requirements and recommendations for developers of intentional genomic alterations in animals, as part of its efforts to oversee these genetic modifications.
The FDA has released a revised final guidance on food allergen labeling, addressing issues related to the Food Allergen Labeling and Consumer Protection Act of 2004 and the Food Allergy Safety, Treatment, Education, and Research Act of 2021.
The FDA has released a final guidance to set action levels for lead in certain processed foods intended for babies and young children under 2 years old, aiming to further reduce lead in the food supply.
The Food and Drug Administration (FDA) has announced the availability of a draft guidance for industry on best practices for naming and labeling plant-based alternative foods, which are marketed as alternatives to animal-derived foods.
The FDA and OHRP have released a draft guidance on including tissue biopsies in clinical trials, providing recommendations for industry, investigators, institutions, and IRBs. The guidance addresses tissue biopsies in adults and children as part of clinical trials evaluating investigational medical products.
The FDA is releasing a draft guidance to encourage the inclusion of more female participants in clinical trials and to provide recommendations for analyzing sex-specific data, as part of its efforts to improve the generalizability of medical product results.
The FDA has issued a final guidance to help establishments reduce the risk of sepsis-related infections in human cells, tissues, and products, in response to a public health safety concern and to address the urgent need for updated recommendations in donor eligibility determinations.
The FDA has released a final guidance for industry regarding communications of scientific information on unapproved uses of approved/cleared medical products to healthcare providers. This guidance finalizes a revised draft issued in October 2023, replacing a previous draft from 2014.
The US Food and Drug Administration (FDA) has announced the availability of a draft guidance document that provides recommendations for the non-clinical and clinical performance testing, labeling, and premarket submission of pulse oximeters for medical purposes.
The FDA has released a final guidance to help the tobacco industry improve the accuracy and reliability of analytical testing methods for tobacco products, building on a draft released in 2021.
The FDA has released a draft guidance to help the pharmaceutical industry use artificial intelligence to support regulatory decision-making for drug and biological products, aiming to improve public health.
The FDA has released a draft guidance outlining recommendations for the lifecycle management and marketing of devices with artificial intelligence (AI)-enabled software functions, aiming to support the agency's evaluation of safety and effectiveness.
The US Food and Drug Administration (FDA) has released a final guidance to help establishments screen donors for tuberculosis, a disease caused by Mycobacterium tuberculosis, until approved screening tests become available.
The FDA has released a final guidance on compounding using bulk drug substances, replacing a previous version from 2017. The guidance outlines FDA's interim policy on outsourcing facilities using bulk substances while the agency develops a list of approved substances.
The FDA has released a final guidance on compounding using bulk drug substances, outlining its interim policy on the practice while it develops a list of approved substances under the FD&C Act.
The FDA has released a final guidance document outlining the requirements for device manufacturers to notify the agency of a permanent discontinuance or interruption in manufacturing, updating previous guidance issued on November 17, 2023.
The Office of the Chief of Protocol at the Department of State is seeking U.S. cities to submit proposals to host a series of G20 meetings in 2026, marking the United States' host year of the global summit.
The U.S. government has amended a major disaster declaration for the state of North Carolina, which was initially declared on September 28, 2024, due to the impact of Tropical Storm Helene.
The Federal Trade Commission (FTC) is requesting the Office of Management and Budget (OMB) to extend the clearance for information collection requirements under the Red Flags, Card Issuers, and Address Discrepancy Rules for an additional three years, until January 31, 2028.
The House Committee on Oversight and Reform will hold Sunshine Act meetings this week, with the first meeting scheduled for Wednesday, and the final meeting taking place on Friday, as part of their ongoing oversight efforts.
The US Department of Health and Human Services is proposing modifications to the HIPAA Security Rule to enhance the cybersecurity of electronic protected health information, addressing changes in healthcare environments, increased breaches, and common compliance deficiencies.